4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-16-000086
CEO bought 24,083 shares at an average $0.12 ($2,910)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-07-25 | Purchase : show line 1 in the form | +19,083 | $0.11 | $2,175 | 7,127,202 | D |
| 2016-07-25 | Purchase : show line 2 in the form | +5,000 | $0.15 | $735 | 7,132,202 | D |
| Open-market purchases · 24,083 sh · avg $0.12 · $2,910 | ||||||
Loading xslF345X03/primary_doc.xml…